Transport Pharmaceuticals
Framingham
About Transport Pharmaceuticals
Transport Pharmaceuticals, Inc. develops drug/device combination products for the treatment of dermal diseases. The company offers SoloVir electrokinetic transdermal system (ETS) for the treatment of herpes labialis or cold sores; transungual ETS for the treatment of onychomycosis; steroid delivery ETS for the treatment of mild to moderate adult acne and psoriasis; and ETS imiquimod for actinic keratosis treatment. Transport Pharmaceuticals, Inc. was founded in 1999 and is based in Framingham, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.8M
- Last round: Debt Financing (Oct 2009)
- Website: transportpharma.com
- Phone: 508-872-0433
Industries & Categories
Health Care, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/transport-pharmaceuticals-2836186 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.